Terms: = Bone cancer AND PSA AND Treatment
1142 results:
1. Salvage Radiotherapy PSMA PET/CT-guided in Men With psa Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
2. A pictorial view on false positive findings of
Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
[TBL] [Abstract] [Full Text] [Related]
3. [
Emmett L; Subramaniam S; Crumbaker M; Nguyen A; Joshua AM; Weickhardt A; Lee ST; Ng S; Francis RJ; Goh JC; Pattison DA; Tan TH; Kirkwood ID; Gedye C; Rutherford NK; Sandhu S; Kumar AR; Pook D; Ramdave S; Nadebaum DP; Voskoboynik M; Redfern AD; Macdonald W; Krieger L; Schembri G; Chua W; Lin P; Horvath L; Bastick P; Butler P; Zhang AY; Yip S; Thomas H; Langford A; Hofman MS; McJannett M; Martin AJ; Stockler MR; Davis ID;
Lancet Oncol; 2024 May; 25(5):563-571. PubMed ID: 38621400
[TBL] [Abstract] [Full Text] [Related]
4. [Role of bone Scan Index (BSI) in the Prognosis and treatment Efficacy in Castration-Sensitive Prostate cancer Patients with bone Metastasis].
Deguchi K; Sasaki T; Oue H; Okamoto T; Kato M; Kajiwara S; Higashi S; Masui S; Nishikawa K; Inoue T
Hinyokika Kiyo; 2024 Feb; 70(2):29-37. PubMed ID: 38447942
[TBL] [Abstract] [Full Text] [Related]
5. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
6. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer.
Sun J; Tian T; Wang N; Jing X; Qiu L; Cui H; Liu Z; Liu J; Yan L; Li D
Front Endocrinol (Lausanne); 2024; 15():1338420. PubMed ID: 38384968
[TBL] [Abstract] [Full Text] [Related]
7. The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer.
Saylor PJ; Kozin SV; Matsui A; Goldberg SI; Aoki S; Shigeta K; Mamessier E; Smith MR; Michaelson MD; Lee RJ; Duda DG
Radiother Oncol; 2024 Mar; 192():110091. PubMed ID: 38224917
[TBL] [Abstract] [Full Text] [Related]
8. The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate cancer: A Multicenter Study.
Marra G; Rajwa P; Filippini C; Ploussard G; Montefusco G; Puche-Sanz I; Olivier J; Zattoni F; Moro FD; Magli A; Dariane C; Affentranger A; Grogg JB; Hermanns T; Chiu PK; Malkiewicz B; Kowalczyk K; Van den Bergh RCN; Shariat SF; Bianchi A; Antonelli A; Gallina S; Berchiche W; Sanchez-Salas R; Cathelineau X; Afferi L; Fankhauser CD; Mattei A; Karnes RJ; Scuderi S; Montorsi F; Briganti A; Deandreis D; Gontero P; Gandaglia G;
Clin Genitourin Cancer; 2024 Apr; 22(2):244-251. PubMed ID: 38155081
[TBL] [Abstract] [Full Text] [Related]
9. GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
Yokomizo A; Shiota M; Morokuma F; Eto M; Matsuyama H; Matsumoto H; Kamoto T; Terada N; Kawahara K; Enokida H; Tatarano S; Fujimoto N; Higasijima K; Sakai H; Hakariya T; Igawa T; Suekane S; Kamba T; Sugiyama Y; Kishimoto J; Naito S
Int J Urol; 2024 Apr; 31(4):362-369. PubMed ID: 38148124
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Prostate cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence Reporting Scoring System.
Pecoraro M; Dehghanpour A; Das JP; Woo S; Panebianco V
Radiol Clin North Am; 2024 Jan; 62(1):135-159. PubMed ID: 37973239
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
[TBL] [Abstract] [Full Text] [Related]
12. Lifetime Follow-Up of a Patient with Metastatic Prostate cancer Undergoing Multiple Surgical Resections: A Case Report.
Nanashima A; Nagayasu T; Yamasaki N; Tsuchiya T; Matsumoto K; Tagawa T; Arai J
Am J Case Rep; 2023 Nov; 24():e941668. PubMed ID: 37939016
[TBL] [Abstract] [Full Text] [Related]
13. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate cancer in the United States.
Yee CW; Harvey MJ; Xin Y; Kirson NY
Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
[TBL] [Abstract] [Full Text] [Related]
14. Establishment and assessment of a nomogram for predicting prognosis in bone-metastatic prostate cancer.
Liu W; Wang Z; Wu Y; Li L
Medicine (Baltimore); 2023 Nov; 102(44):e35693. PubMed ID: 37933039
[TBL] [Abstract] [Full Text] [Related]
15. Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study.
Mytilekas VK; Papaefstathiou E; Koukourikis P; Ouzounidis X; Kazantzidis S; Hatzimouratidis K
Investig Clin Urol; 2023 Nov; 64(6):572-578. PubMed ID: 37932568
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic accuracy of fully hybrid [
Ghezzo S; Mapelli P; Samanes Gajate AM; Palmisano A; Cucchiara V; Brembilla G; Bezzi C; Suardi N; Scifo P; Briganti A; De Cobelli F; Chiti A; Esposito A; Picchio M
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):907-918. PubMed ID: 37897615
[TBL] [Abstract] [Full Text] [Related]
17. A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [
Zang J; Wang G; Zhao T; Liu H; Lin X; Yang Y; Shao Z; Wang C; Chen H; Chen Y; Zhu Z; Miao W; Chen X; Zhang J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):871-882. PubMed ID: 37864592
[TBL] [Abstract] [Full Text] [Related]
18. [Transurethral plasma resection of the prostate for acute urinary retention in patients with advanced prostate cancer].
Pang K; Liang Q; Chen B; Shi ZD; Dong Y; Han CH
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):25-30. PubMed ID: 37846828
[TBL] [Abstract] [Full Text] [Related]
19. EMAS position statement: Testosterone replacement therapy in older men.
Kanakis GA; Pofi R; Goulis DG; Isidori AM; Armeni E; Erel CT; Fistonić I; Hillard T; Hirschberg AL; Meczekalski B; Mendoza N; Mueck AO; Simoncini T; Stute P; van Dijken D; Rees M; Lambrinoudaki I
Maturitas; 2023 Dec; 178():107854. PubMed ID: 37845136
[TBL] [Abstract] [Full Text] [Related]
20. The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Almuradova E; Seyyar M; Arak H; Tamer F; Kefeli U; Koca S; Sen E; Telli TA; Karatas F; Gokmen I; Turhal NS; Sakalar T; Ayhan M; Ekinci F; Hafizoglu E; Kahraman S; Kesen O; Unal C; Alan O; Celik S; Yekeduz E; Omur O; Gokmen E
Int J Cancer; 2024 Feb; 154(4):692-700. PubMed ID: 37818966
[TBL] [Abstract] [Full Text] [Related]
[Next]
